93 Search Results for

CAP-AI cohort 1 team publishes new paper: Online health forums: a treasure trove of insights into patient experience and concerns

Research involving the Turing is using AI to extract invaluable information about patients’ individual journeys The development of new and effective drugs, health services and policies requires close cooperation between clinical researchers, the pharmaceutical industry and patients. For this reason, regulators worldwide, including the US Food and Drug Administration and the European Medicines Agency, are pushing for patients and their...

Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records

Barts Life Sciences’ CAP-AI fellow Dayem Ullah and principal investigators Claude Chelala and Hemant Kocher have published a new paper in the BMC cancer journal on their project analysing the temporality of clinical factors associated with pancreatic cancer using linked electronic health records. The full article can be found here: https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-09014-w Abstract Background Pancreatic cancer risk is poorly quantified in...

Are you a talented innovation manager? Barts Life Sciences is recruiting now:

An exciting opportunity to be involved at the cutting edge of life sciences innovation in east London. Barts Life Sciences is Barts Health NHS Trust’s and Queen Mary University of London’s programme for using research, innovation and technologies to transform health and care services. This covers a broad range of activities from discovery science, product development and testing, and the...

London & Partners Diversity in Health Series – featuring Barts Life Sciences CAP-AI PI and Consultant Ophthalmologist DR Samantha Gordon

Barts Life Sciences CAP-AI principal investigator Dr Samantha Gordon talks about the importance of including every race in artificial intelligence projects in the first video of this exciting new series by London & Partners, London’s business growth and destination agency: https://www.linkedin.com/posts/london-%26-partners_london-health-innovation-through-diversity-activity-6871410217381318656-q0Z3

HDR UK opens applications for Health Data Science Black Internship Programme 2022

About the programme Overview Run by Health Data Research UK (HDR UK) and the UK Health Data Research Alliance (the ‘Alliance’) in partnership with 10,000 Black Interns initiative, our Health Data Science Black Internship Programme provides an exciting new endeavour for early career Black data scientists who are currently heavily under-represented within the health data science. Our Health Data Science Black Internship Programme is just...

HDR UK and Barts Life Sciences are recruiting for a health data scientist

An exciting opportunity for a healthcare data scientist – the post holder will support cross regional data analysis for a project which is enabling regional, acute hospital admissions data to support vaccine safety research. To enable surveillance and research on the COVID-19 vaccination programme and other rare events there is a critical need for rapid, near real time and more...

Barts Life Sciences opens new talent hub at Newham College

In an effort to encourage more young people to work for the NHS, Barts Life Sciences, a joint research programme led by Barts Health NHS Trust and Queen Mary University of London, have opened a new training facility for health care and life sciences in east London in partnership with Newham College. The facility – known as the Barts Health...

Barts Life Sciences is recruiting for a digital fellow

Barts Life Sciences is recruiting for a digital fellow for our programme of AI and machine learning projects, CAP-AI. This project, ThyrAI, will develop automatic interpretation of thyroid biopsy specimen slides for automated diagnosis using machine and deep learning approaches. Computer programs can then be devised for feature extraction from image data and feeding of this information to classifiers for...

OPTIMA: Improving treatment for patients with prostate, breast and lung cancer through artificial intelligence

Professors Claude Chelala and Louise Jones from Barts Cancer Institute, Queen Mary University of London, are part of a €21.3 million public-private research programme that will seek to use artificial intelligence (AI) to improve care for patients with prostate, breast and lung cancer. The aim of the research project, named OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial intelligence), is to design, develop and...